Louisiana 2026 Regular Session

Louisiana House Bill HB792

Introduced
2/27/26  
Refer
2/27/26  

Caption

Provides relative to the creation of screening procedures for the purpose of testing inmates for certain infectious diseases

Impact

If enacted, HB 792 will have a significant impact on public health within correctional facilities in Louisiana. By requiring systematic screening, it seeks to identify and treat inmates with HIV and hepatitis C early, potentially improving health outcomes and reducing the spread of these diseases. Funding for the medical treatments will be sourced from state appropriations, existing pharmaceutical agreements, and other federal funding streams. The bill ensures that neither local sheriffs nor parish governing authorities will bear the costs of medications for inmates tested positive, thereby alleviating financial burdens on local governments.

Summary

House Bill 792 aims to establish standardized screening procedures for infectious diseases, specifically HIV and hepatitis C, for inmates in correctional facilities across Louisiana. This bill mandates the Department of Public Safety and Corrections (DPS&C) to implement these procedures to enhance the detection and treatment of these infections. The proposed law allows inmates the option to decline participation in the screening without affecting their privileges or service eligibility. The bill defines various terms related to the correctional system and details the implementation and documentation processes for the screenings.

Sentiment

The sentiment around HB 792 appears to be generally supportive among health advocates and public health officials who recognize the need for better healthcare services within prisons. However, there may be some contention regarding the implementation and funding mechanisms, as local authorities might have concerns over the sustainable financial practices required to support this initiative. The confidentiality provisions included in the bill also aim to protect inmate privacy, which is a crucial element in garnering support for such health measures.

Contention

Key points of contention regarding HB 792 may arise from the financial implications of the mandated screenings and treatments, particularly if appropriations are not guaranteed by the state legislature. While the bill seeks to prioritize treatment for certain inmates, the reliance on state funding and reimbursement procedures may be criticized. Additionally, opposition may stem from concerns about the adequacy of the screening protocols and their effectiveness in a correctional setting. Overall, the successful implementation of such procedures will depend on coordinated efforts between state authorities and local facilities.

Companion Bills

No companion bills found.

Previously Filed As

LA SB174

Provides relative to certain pregnancy screenings. (gov sig) (EN INCREASE GF EX See Note)

LA HB27

Provides relative to the release of inmates during a declared disaster

LA HB388

Provides relative to the amount DPS&C pays for the housing of state inmates in a parish jail or institution (EG SEE FISC NOTE GF EX)

LA SB121

Provides for mental health screenings in schools. (8/1/25) (EN SEE FISC NOTE LF EX)

LA HB400

Provides relative to a minor's consent for medical procedures and treatments

LA HR322

Creates a task force to study public health outcomes related to incurable sexually transmitted diseases

LA HB76

Creates the crime of felony intentional infection of a sexually transmitted disease (RE SEE FISC NOTE GF EX)

LA HCR75

Creates the Chronic Wasting Disease Task Force

LA HB571

Provides for the classification of certain marine vessels for purposes of ad valorem taxes (OR NO IMPACT LF RV See Note)

LA HB222

Provides for the assessment of bank stocks for purposes of calculating ad valorem tax liability of certain banks (OR DECREASE LF RV See Note)

Similar Bills

TX HB1559

Relating to prohibited nonconsensual medical procedures and treatment on certain minors with intersex traits.

TX HB3749

Relating to the regulation of the provision of elective intravenous therapy.

MA H2459

Relative to informed consent for concurrent surgical procedures

TX HB778

Relating to required health benefit plan coverage for gender transition adverse effects and reversals.

HI SB107

Relating To Medical Informed Consent.

HI HB215

Relating To Medical Informed Consent.

HI HB215

Relating To Medical Informed Consent.

HI SB107

Relating To Medical Informed Consent.